# Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers

> **NCT04424381** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 72 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Rivaroxaban 20 MG Oral Tablet [Xarelto]
- **DRUG:** Rivaroxaban 20 MG Oral Tablet

## Key facts

- **NCT ID:** NCT04424381
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-04
- **Primary completion:** 2019-09-05
- **Final completion:** 2019-09-20
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04424381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04424381, "Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04424381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*